Lymphatic Filariasis Elimination in Boudh District of Odisha, India: A Success Story

  • MM Pradhan ADPHO, VBD-Health & FW Department, Boudh District, Odisha.
  • Swati Kumari VBD Consultant, Health & FW Department, Boudh District, Odisha.
  • N Somalkar Regional Director ROHFW, Bhubaneswar, Odisha.
  • PK Srivastava Former Joint Director, NVBDCP, Delhi.
Keywords: MDA, ELF, TAS, LF


The National Filaria Control Programme (NFCP) has been running in the country since the year 1955 with the strategy of parasite detection, treatment and vector control mainly in urban areas. In the year 1997, the fiftieth World Health Assembly Resolution listed Lymphatic Filariasis (LF) for elimination by 2020 which now has been aligned with the Sustainable Development Goal to be achieved by 2030. India also started its campaign to eliminate LF in 2004. The main strategy of the elimination programme is the Annual Mass Drug Administration (MDA) to progressively reduce and ultimately interrupt LF transmission. The other pillar of the strategy is morbidity management and disability prevention. Odisha state also started its LF elimination campaign in 20 endemic districts out of a total of 30 districts. There has been variable performance among districts and also within the districts at the Sub-district, Block Primary Health Centres or Health Sub-centre levels. Boudh is a centrally located district of Odisha and is one of the LF endemic districts covered under MDA since 2005.
The average population coverage during MDA in Boudh district was reported to be more than 65% since 2004, however, in the last five rounds of MDA. the Mf rate was < 1% with a compliance of > 80%. The district qualified for undertaking the Transmission Assessment Survey (TAS). The district has been validated for having achieved the elimination threshold by successfully clearing the transmission assessment survey (TAS).

How to cite this article:
Pradhan MM, Kumari S, Somalkar N, Srivastava PK. Lymphatic Filariasis Elimination in Boudh District of Odisha, India: A Success Story. XIV Annual Conference of Indian Society for Malaria & Other Communicable Diseases (ISMOCD). 2023;111-116.



National Health Mission [Internet]; [cited 2023 Jul 10]. Available from:

World Health Assembly. Elimination of lymphatic filariasis as a public health problem. WHA 50.29. Resolutions and Decisions; 1997. p. 27-8.

Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491-503. [PubMed] [Google Scholar]

Ottessen EA. The global programme to eliminate lymphatic filariasis. Trop Med Int Health. 2000;5(9):591-4. [PubMed] [Google Scholar]

National Vector Borne Disease Control Programme. Operational guidelines on elimination of lymphatic filariasis, India. Directorate of National Vector Borne Disease Control; 2005.

National Vector Borne Disease Control Programme. Guidelines on elimination of lymphatic filariasis, India; 2009.

Government of India. Census 2011. Registrar General of India; 2011.

World Health Organization. Global programme to eliminate lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration–TAS. WHO/HTM/NTD/PCT/2011.4. 2011.

National Vector Borne Disease Control Programme [Internet]. National guidelines for Transmission Assessment Survey; 2013 [cited 2023 Jul 21]. Available from:

Srivastava PK, Sharma SN, Bhattacharjee J, Dhariwal AC, Krishnamoorthy K. A tool for monitoring epidemiological impact of Mass Drug Administration (MDA) in the elimination of lymphatic filariasis- an Indian experience. J Commun Dis. 2014;46(2):1-6.

World Health Organization [Internet]. Lymphatic filariasis: practical entomology - a handbook for national elimination programmes; 2013 [cited 2023 Jul 18]. Available from: